Trials / Conditions / Melanoma and Brain Metastases
Melanoma and Brain Metastases
4 registered clinical trials studyying Melanoma and Brain Metastases — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Sym NCT06887088 | Grupo Español Multidisciplinar de Melanoma | Phase 2 |
| Terminated | Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain M NCT01978236 | GlaxoSmithKline | Phase 2 |
| Completed | Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma Tha NCT02039947 | Novartis Pharmaceuticals | Phase 2 |
| Completed | A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain NCT01266967 | GlaxoSmithKline | Phase 2 |